Form 424B3 BOSTON SCIENTIFIC CORP
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260401/AOBZG22C8W22SJZZ2H2C2ZZZL2RGZ2U2ZV82
Filed on: April 1, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $90 at Piper Sandler
- Belo Sun Announces Management Transition
- Â Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
